Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00009945 · ClinicalTrials.gov registry record · Phase 3
Clodronate With or Without Chemotherapy and/or Hormonal Therapy in Treating Women With Stage I or Stage II Breast Cancer
A Phase 3 study, sponsored by NSABP Foundation.
- Completed
- Registry status
- Phase 3
- Development phase
- 3,323
- Enrollment target
NCT00009945 is a Phase 3 study that has completed, run by NSABP Foundation. The registered enrollment target is 3,323 participants.
The verdict
NCT00009945, a Phase 3 study, has completed, sponsored by NSABP Foundation.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 3,323 participants
- Enrollment target
Study Summary
RATIONALE: Clodronate may be effective in preventing the spread of cancer to the bones and other parts of the body. It is not yet known whether clodronate is more effective alone or combined with chemotherapy and /or hormonal therapy in preventing metastatic breast cancer. PURPOSE: Randomized phase III trial to determine the effectiveness of clodronate with or without chemotherapy and /or hormonal therapy in preventing metastases in women who have stage I or stage II breast cancer.
Interventions
- DRUG placebo
- DRUG clodronate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,323 participants |
| Start Date | 2001-01 |
| Est. Completion | 2012-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00009945
The ClinicalTrials.gov registry entry for NCT00009945 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 3,323 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NSABP Foundation, which has 44 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00009945 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00009945 about?
NCT00009945 is a clinical study titled "Clodronate With or Without Chemotherapy and/or Hormonal Therapy in Treating Women With Stage I or Stage II Breast Cancer". RATIONALE: Clodronate may be effective in preventing the spread of cancer to the bones and other parts of the body. It is not yet known whether clodronate is more effective alone or combined with chemotherapy and /or hormonal therapy in preventing metastatic breast cancer. PURPOSE: Randomized phase...
What is the current status of trial NCT00009945?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 3,323 participants. The study started on 2001-01. Estimated completion is 2012-12.
What interventions are being tested in trial NCT00009945?
The interventions under investigation include: placebo (DRUG), clodronate (DRUG).
Who is sponsoring clinical trial NCT00009945?
This trial is sponsored by NSABP Foundation, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.